showing 1461 abstracts from year 2015


filter abstracts


conference:


year:






Details title year
Details G01 LIRAGLUTIDE IS EFFECTIVE IN THE HISTOLOGICAL CLEARANCE OF NON-ALCOHOLIC... 2015
Details G02 LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN IS SAFE AND EFFICACIOUS IN DECOMPE... 2015
Details A PILOT STUDY... 2015
Details G04 ENGINEERED HBV-SPECIFIC T CELLS: DISENTANGLING ANTIVIRAL FROM KILLING C... 2015
Details G06 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL OF TSU-6... 2015
Details O001 C-SALVAGE: GRAZOPREVIR (GZR; MK-5172), ELBASVIR (EBR; MK-8742) AND RIB... 2015
Details O002 TREATMENT OF DECOMPENSATED HCV CIRRHOSIS IN PATIENTS WITH DIVERSE GENO... 2015
Details O003 CAN HEPATITIS C TREATMENT BE SAFELY DELAYED? EVIDENCE FROM THE VETERAN... 2015
Details O005 RETREATMENT OF PATIENTS WHO FAILED 8 OR 12 WEEKS OF LEDIPASVIR/SOFOSBU... 2015
Details O006 C-SWIFT: GRAZOPREVIR/ELBASVIR + SOFOSBUVIR IN CIRRHOTIC AND NONCIRRHOT... 2015
Details O007 ALL ORAL HCV THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH DECOMPENSA... 2015
Details O008 EFFICACY AND SAFETY OF GRAZOPREVIR AND ELBASVIR IN HEPATITIS C GENOTYP... 2015
Details O009 A PROSPECTIVE STUDY OF HEPATITIS B REACTIVATION IN PATIENTS WITH PRIOR... 2015
Details O010 T AND B CELL RESPONSES AND PREVIOUS EXPOSURE TO HEPATITIS B VIRUS IN A... 2015
Details O011 A NATIONWIDE SURVEY OF HEPATITIS E VIRUS INFECTION IN LIVER TRANSPLANT... 2015
Details O012 HEPATITIS DELTA VIRUS CAN SURVIVE LIVER REGENERATION AND IS AMPLIFIED ... 2015
Details O013 EVALUATION OF HDV QUANTIFICATION ASSAYS WORLDWIDE: RESULTS OF THE FIRS... 2015
Details O014 A TARGETED RNAi SCREEN USING A HIGH-THROUGHPUT INFECTIOUS MODEL SYSTEM... 2015
Details O015 QUANTITATIVE MEASUREMENTS OF MUTATIONS IN BASAL CORE PROMOTOR REGION S... 2015
Details O016 HEPATITIS B SURFACE ANTIGEN AND DNA LEVELS CAN IDENTIFY INACTIVE CARRI... 2015

1 2 3 4 5 6 7 8 ...74 Next